Sugammadex
Educational summary, not a formulary. Dosing is quoted from the Makindo chapters and topics site. The other sections are draft summaries not yet checked line by line against the BNF or SPC. Check dose, indication, interactions and monitoring in the BNF entry for Sugammadex and local guidelines before prescribing.
Reversal agent
Mechanism
Cyclodextrin encapsulating rocuronium and vecuronium.
Uses
Reversal of rocuronium or vecuronium neuromuscular block.
Dosing
- Neuromuscular blocker — rocuronium 1–1.2 mg/kg (onset about 60 seconds; reversible with sugammadex ) or suxamethonium 1–1.5 mg/kg (onset 30–60 seconds, short-acting).
Anaesthesia: Airway management and anaesthetic drugs - Sugammadex — a modified cyclodextrin that encapsulates rocuronium (and vecuronium) — can reverse even deep block (16 mg/kg for immediate reversal after RSI dose); reduces the effectiveness of hormonal contraception (extra precautions for 7 days); anaphylaxis (rare).
Anaesthesia: Airway management and anaesthetic drugs - Rocuronium | RSI dose 1–1.2 mg/kg; reversed by sugammadex
Anaesthesia: Airway management and anaesthetic drugs
Side effects
Hypersensitivity, bradycardia, laryngospasm.
Interactions
Hormonal contraceptives become less effective for 7 days.
Contraindications and cautions
Hypersensitivity
Monitoring
Neuromuscular function
Pregnancy and breastfeeding
Use if needed
Renal and hepatic impairment
Avoid in severe renal impairment
Overdose and reversal
Not applicable
Special advice
Counsel women to use extra contraception for 7 days.
More from the textbook: uses, cautions and other points
- Rocuronium , atracurium (non-depolarising) - reversed by neostigmine (with glycopyrronium) or sugammadex (rocuronium and vecuronium); people with myasthenia are very sensitive to them.
Neurology: Anatomy, Physiology and Pharmacology - Muscle relaxation when needed - neuromuscular blockers (rocuronium, atracurium; suxamethonium for rapid sequence); reversed with neostigmine or sugammadex.
Surgery: Surgical principles and perioperative care - Sugammadex can reverse rocuronium but is itself a rare cause of anaphylaxis.
Clinical Immunology: Allergy, anaphylaxis, urticaria and angioedema - Emergence — stop anaesthetic agents, reverse neuromuscular blockade (neostigmine with glycopyrronium, or sugammadex for rocuronium) — check with a nerve stimulator (train-of-four ratio over 0.9) — extubate when awake with airway reflexes (or deep in selected cases).
Anaesthesia: Preoperative assessment and principles of anaesthesia - Difficult Airway Society (DAS) guidelines for unanticipated difficult intubation in adults (2015 — updated guidance 2025) — a stepwise plan with oxygenation as the priority : Plan Aim Actions Plan A Facemask ventilation and tracheal intubation Optimise position, preoxygenate, videolaryngoscopy, bougie, external laryngeal manipulation; …
Anaesthesia: Airway management and anaesthetic drugs - Plan C | Final attempt at facemask ventilation | Two-person technique with adjuncts; ensure full neuromuscular blockade; if successful — wake the patient (sugammadex if rocuronium)
Anaesthesia: Airway management and anaesthetic drugs - Rocuronium (aminosteroid) — fast onset at high dose (RSI), intermediate duration; reversed by sugammadex .
Anaesthesia: Airway management and anaesthetic drugs - Pill failure 1 week after surgery with sugammadex reversal | Sugammadex reduces hormonal contraception
Anaesthesia: Airway management and anaesthetic drugs
Where it is discussed in the book
- Neurology: Anatomy, Physiology and Pharmacology (1 mention)
- Surgery: Surgical principles and perioperative care (1 mention)
- Clinical Immunology: Allergy, anaphylaxis, urticaria and angioedema (1 mention)
- Anaesthesia: Preoperative assessment and principles of anaesthesia (1 mention)
- Anaesthesia: Airway management and anaesthetic drugs (9 mentions)